Page 746 - Read Online

Wu et al. Hepatoma Res 2018;4:66 I http://dx.doi.org/10.20517/2394-5079.2018.87 Page 11 of 11

26. Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, et al. NAFLD as a sexual dimorphic disease: role of gender and
reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther
2017;34:1291-1326.
27. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with
cirrhosis: a meta-analysis. PLoS Med 2014;11:e1001624.
28. Singal AG, Volk ML, Rakoski MO, Fu S, Su GL, et al. Patient involvement in healthcare is associated with higher rates of surveillance for
hepatocellular carcinoma. J Clin Gastroenterol 2011;45:727-32.
29. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, et al. Use of surveillance for hepatocellular carcinoma among patients with
cirrhosis in the United States. Hepatology 2010;52:132-41.
30. Palmer LB, Kappelman MD, Sandler RS, Hayashi PH. Surveillance for hepatocellular carcinoma in a medicaid cirrhotic population. J Clin
Gastroenterol 2013;47:713-8.
31. Ahmed Mohammed HA, Yang JD, Giama NH, Choi J, Ali HM, et al. Factors influencing surveillance for hepatocellular carcinoma in
patients with liver cirrhosis. Liver Cancer 2017;6:126-36.
32. Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, et al. Is female sex a significant favorable prognostic factor in hepatocellular
carcinoma? Eur J Gastroenterol Hepatol 2009;21:1212-8.
33. Simon TG, King LY, Chong DQ, Nguyen LH, Ma Y, et al. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: results
from two prospective cohort studies. Hepatology 2018;67:1797-1806.
34. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, et al. Disparities in liver transplantation before and after introduction of
the MELD score. JAMA 2008;300:2371-8.
35. Bryce CL, Angus DC, Arnold RM, Chang CC, Farrell MH, et al. Sociodemographic difference in early access to liver transplant services.
Am J Transplant 2009;9:2092-101.
36. Oloruntoba OO, Moylan CA. Gender-based disparities in access to and outcomes of liver transplantation. World J Hepatol 2015;7:460-7.
37. Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, et al. Reduced access to liver transpaltnation in women: role of height, MELD
exception scores, and renal function underestimation. Transplantation 2018;102:1710-6.
38. Cholongitas E, Marelli L, Kerry A, Goodier DW, Nair D, et al. Female liver transplant recipients with the same GFR as male recipients have
lower MELD scores--a systematic bias. Am J Transplant 2007;7:685-92.
39. Lai JC, Terrault NA, Vittinghoff E, Biggins SW. Height contributes to the gender difference in wait-list mortality under the MELD-based
liver allocation system. Am J Transplant 2010;10:2658-64.
40. Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, et al. Impact of sex on the survival of patients with hepatocellular carcinoma: a
surveillance, epidemiology, and end results analysis. Cancer 2014;120:3707-16.